Property and equipment includes assets from capital leases totaling $150,427 and accumulated depreciation of $22,452 at December 31, 2003.
Depreciation and amortization expense for 2003, 2002 and 2001 was $6,040,793, $5,614,274 and $7,512,453, respectively.
In 2001, the Company entered into a line of credit agreement with a financial institution. The line of credit allows the Company to borrow the lesser of $5,000,000 or 80% of eligible accounts receivable, as defined, at an interest rate of prime plus 3.5%. The Company was subject to an annual interest rate of 7.5% and 9.5% at December 31, 2003 and 2002, respectively. Substantially all assets of the Company serve as collateral for the line of credit. Outstanding borrowings were $1,499,707 and $0 as of December 31, 2003 and 2002, respectively.
In connection with the line of credit, the financial institution was issued fully vested warrants to purchase 125,000 shares of the Company’s Common stock at an exercise price of $1.00 per share. In 2001, the Company recorded non-cash commissions totaling $56,807 in the accompanying consolidated statement of operations relating to the grant of the warrants.
NOTE G –MANDATORILY REDEEMABLE CONVERTIBLE PREFERRED STOCK, BRIDGE NOTES AND WARRANTS
As of December 31, 2003, the Company has authorized 100,000,000 shares of Preferred stock with a par value of $.01 per share, of which 16,500,000 shares have been designated as Series A-1 mandatorily redeemable convertible preferred stock (Series A-1), 11,000,000 shares have been designated as Series B-1 mandatorily redeemable convertible preferred stock (Series B-1), 47,000,000 shares have been designated as Series C-1 mandatorily redeemable convertible preferred stock
NOTE G –MANDATORILY REDEEMABLE CONVERTIBLE PREFERRED STOCK, BRIDGE NOTES AND WARRANTS - continued
(Series C-1) and 23,500,000 shares have been designated as Series D-1 mandatorily redeemable convertible preferred stock (Series D-1), collectively (Series A-1, B-1, C-1 and D-1).
The holders of Series A-1, B-1, C-1 and D-1 are entitled to liquidation preferences equal to the original purchase price, plus all accrued but unpaid dividends. The Series D-1 preference is senior to the preferences of Series A-1, B-1 and C-1 and would be distributed in full to the Series D-1 holders before any distribution to the holders of Series A-1, B-1 and C-1.
The holders of the Series A-1, B-1, C-1 and D-1 are entitled to receive cumulative dividends at an annual rate of 8%. The Series A-1, B-1, C-1 and D-1 are redeemable at the option of the holders and upon the receipt of notice of the election of 75% of said holders of each Series, in December 2006.
The Series A-1, B-1, C-1 and D-1 are convertible at any time into common stock at the holders’ option at a conversion rate of one-to-three and one third (1:3 1/3), one-to-one and one half (1:1 1/2), one-to-one (1:1) and one-to-one (1:1), respectively, at December 31, 2003. All outstanding shares of the Series A-1, B-1, C-1 and D-1 are automatically convertible into common stock upon the closing of a qualified underwritten public offering, as defined. The holders of Series A-1, B-1, C-1 and D-1 are entitled to certain voting, anti-dilution and registration rights, as defined.
The Company would have issued 120,185,988 and 103,519,321 shares of Common stock had all of Series A-1, B-1, C-1 and D-1 been converted at December 31, 2003 and 2002, respectively.
In August 2003, the Company sold 16,666,667 shares of Series D-1 at $0.30 per share for proceeds of $4,914,553, net of offering costs of $85,447. In addition, the Series D-1 investors received warrants to purchase 4,837,551 shares of Series D-1 at $0.30 per share.
The Company allocated the proceeds to the Series D-1 and the warrants based on their relative fair values. The fair value of the warrants was based on the Black-Scholes option-pricing model. As a result, the Company allocated $4,044,633 to the Series D-1 and $955,337 to the warrants.
The cost allocated to the warrants is being amortized as a dividend using the effective interest method from the date of issue of Series D-1 through the redemption date. For 2003, the Company recorded a total of $95,533 of amortization.
In June 2002, the Company sold 39,011,536 shares of Series C-1 at $0.30 per share for proceeds of $11,416,258, net of offering costs of $287,203.
In May 2002, the Company sold 8,560,745 shares of Series B-1 at $0.45 per share for proceeds of $3,748,236, net of offering costs of $104,098. The proceeds included the conversion of the March and April 2002 bridge notes in the amount $2,690,000 and accrued coupon interest of $33,674.
S-22
NOTE G –MANDATORILY REDEEMABLE CONVERTIBLE PREFERRED STOCK, BRIDGE NOTES AND WARRANTS - continued
In January and February 2002, the Company sold, in the aggregate, 2,500,000 shares of Series A-1 at $1.00 per share for proceeds of $2,500,000.
In December 2001, the Company sold 8,500,000 shares of Series A-1 at $1.00 per share for proceeds of $7,560,241, net of offering costs of $939,759, and two investors converted $3,000,000 of the November 2001 bridge note plus prepayment penalty into 4,500,000 shares of Series A-1.
The offering costs for each series of preferred stock will be accreted using the effective interest method from the date the shares were issued through the redemption date. For 2003 and 2002, the Company recorded a total of $378,204 and $230,579 of such accretion for the Series A-1, B-1, C-1 and D-1.
Conversion price adjustments
In connection with the issuance of the Series D-1 and warrants, the holders of the Series A-1, B-1 and C-1 agreed to waive the anti-dilution provisions of these securities. As such, no adjustment was made to the conversion features of the Series A-1, B-1 and C-1 as a result of the issuance of Series D-1.
In connection with the issuance of the Series C-1 in June 2002, the conversion price of the Series A-1, Series B-1 and the warrants to purchase Series A-1 was adjusted to $0.30 per share from $0.45. This conversion price adjustment created a beneficial conversion feature for financial reporting purposes. Upon the issuance of the Series C-1, the Company recorded a preferred stock dividend to the Series A-1, Series B-1 and warrants to purchase Series A-1 of $17,222,222, $1,926,168 and $896,666, respectively, in the accompanying consolidated statements of operations.
In connection with the issuance of the Series B-1 in May 2002, the conversion price of the Series A-1 and the warrants to purchase Series A-1 was adjusted to $0.45 per share from $1.00. This conversion price adjustment created a beneficial conversion feature for financial reporting purposes. Upon the issuance of the Series B-1, the Company recorded a preferred stock dividend to the Series A-1 and warrants to purchase Series A-1 of $18,944,444 and $986,334, respectively, in the accompanying consolidated statements of operations.
In connection with the issuance of the April 2001 bridge note, the conversion price of Series A and Series B was adjusted to $3.46 per share from $4.50. This conversion price adjustment created a beneficial conversion feature for financial reporting purposes. Upon the issuance of the bridge note, the Company recorded a preferred stock dividend to the Series A and Series B of $7,213,873 and $781,503, respectively, in the accompanying consolidated statements of operations.
Accounting for bridge notes and warrants
In March and April 2002, the Company issued bridge notes in the aggregate of $2,690,000. The bridge notes bore interest at 12% per annum and had a maturity date of one year from the date of issuance. The note holders were also issued warrants to purchase 807,000 shares of Series A-1 at an exercise price of $1.00 per share.
S-23
NOTE G –MANDATORILY REDEEMABLE CONVERTIBLE PREFERRED STOCK, BRIDGE NOTES AND WARRANTS - continued
The Company allocated the proceeds from the bridge note to the note and the warrant based on their relative fair values. The fair value of the note was determined based on a discounted cash flow analysis using a discount rate of 30%. The fair value of the warrant was based on the Black-Scholes option-pricing model. As a result, the Company allocated $2,151,282 to the notes and $538,718 to the warrants.
The Company recognized interest expense on the note of $572,392 in 2002, of which $33,674 was accrued coupon interest and $538,718 was amortization of the debt discount. In May 2002, the principal amount of the note and coupon interest were converted into Series B-1.
In November 2001, the Company issued a $3,100,000 bridge note to two investors and the Company’s CEO. The bridge note was convertible into a subsequent series of mandatorily redeemable convertible preferred stock at the offering price of a subsequent closing of mandatorily redeemable convertible preferred stock. The bridge note bore interest at 15% and the principal was due on November 13, 2002. The bridge note also bore a prepayment penalty of 50%. In December 2001, in connection with the close of Series A-1, the principal amount of the notes held by two investors and prepayment penalty were converted into Common stock. The note held by the Company’s CEO was repaid during 2002.
In April 2001, the Company issued a $22,500,000 bridge note to several investors. The bridge note was convertible into a subsequent series of mandatorily redeemable convertible preferred stock at the offering price of a subsequent closing of mandatorily redeemable convertible preferred stock. The bridge note bore interest at 12% prior to the due date of September 15, 2001 and 18% thereafter. In connection with the bridge note, the note holders were issued warrants to purchase 3,251,445 shares of Series C at an exercise price of $3.46 per share.
The Company allocated the proceeds from the bridge note to the note and the warrant based on their relative fair values. The fair value of the note was determined based on a discounted cash flow analysis using a discount rate of 30%. The fair value of the warrant was based on the Black-Scholes option-pricing model. As a result, the Company allocated $20,232,483 to the note and $2,267,518 to the warrant.
The Company recognized interest expense on the note of $4,292,518 in 2001, of which $2,025,000 was accrued coupon interest and $2,267,518 was amortization of the debt discount. In December 2001, in connection with the close of Series A-1, the principal amount of the note and coupon interest were converted into Common stock and the warrants were cancelled.
In connection with the April 2001 bridge note, the Company agreed to issue warrants to purchase an additional 5,202,312 shares of Series C at an exercise price of $3.46 per share. These additional shares were issuable only in the event the Company failed to consummate a subsequent series of mandatorily redeemable convertible preferred stock by September 15, 2001. The subsequent series of mandatorily redeemable convertible preferred stock occurred in December 2001. Accordingly, the Company issued warrants to purchase 5,202,312 shares of Series C. Management determined that the value of the warrants was zero and in connection with the recapitalization in December 2001, all of the warrants were cancelled.
S-24
NOTE H – COMMON STOCK AND COMMON STOCK WARRANTS
Common stock
In connection with the recapitalization of the Company in December 2001, certain investors surrendered 829,479 shares of Common stock to the Company.
Common stock warrants
In April 2001, the Company granted warrants to the Series C investors to purchase 437,115 shares of Common stock at $0.05 per share. The warrants vested immediately. The Company recorded a deemed preferred dividend in the amount of $2,486,378. In July 2001, warrants to purchase 25,712 were exercised. In December 2001, in connection with the close of Series A-1, warrants to purchase 321,408 shares were cancelled.
NOTE I – STOCK OPTIONS
Effective December 13, 2001, the Company adopted the 2001 Stock Plan (the Plan). The Plan provides for the granting of incentive and nonqualified stock options to employees and consultants of the Company. The Compensation Committee of the Board of Directors administers the Plan and awards grants and determines the terms of such grants at its discretion. The Company has reserved approximately 24,000,000 shares of Common stock for issuance pursuant to the Plan.
Information with respect to the Company’s common stock options is as follows:
| | Shares | | Exercise price | | Weighted average exercise price | |
| |
| |
| |
| |
Balance, December 31, 2000 | | | 1,562,458 | | $ | 0.16-41.57 | | $ | 22.42 | |
| Granted at fair market value | | | 454,372 | | | 7.79-41.57 | | | 16.83 | |
| Exercised | | | (2,452 | ) | | 0.16 | | | 0.16 | |
| Canceled | | | (557,750 | ) | | 0.16-41.57 | | | 21.15 | |
| |
|
| |
|
| |
|
| |
Balance, December 31, 2001 | | | 1,456,628 | | | 0.16-41.57 | | | 21.20 | |
| Granted at fair market value | | | 22,972,024 | | | 0.24-1.00 | | | 0.33 | |
| Exercised | | | (84,230 | ) | | 0.16-0.24 | | | 0.16 | |
| Canceled | | | (1,557,330 | ) | | 0.16-41.57 | | | 10.64 | |
| |
|
| |
|
| |
|
| |
Balance, December 31, 2002 | | | 22,787,092 | | | 0.16-41.57 | | | 0.96 | |
| Granted at fair market value | | | 3,056,226 | | | 0.24 | | | 0.24 | |
| Exercised | | | (25,753 | ) | | 0.16-0.24 | | | 0.18 | |
| Canceled | | | (4,304,856 | ) | | 0.16-41.57 | | | 1.44 | |
| |
|
| |
|
| |
|
| |
Balance, December 31, 2003 | | | 21,512,709 | | $ | 0.16-41.57 | | $ | 0.77 | |
| |
|
| |
|
| |
|
| |
All options have terms ranging from 2 to 10 years and generally vest over 3 to 4 years. The total number of shares available for future grants under the Plan was 2,356,241 as of December 31, 2003.
S-25
NOTE I – STOCK OPTIONS - continued
The following table summarizes information relating to the Plan as of December 31, 2003 based upon each exercise price:
| Outstanding stock options | | Exercisable stock options | |
|
| |
| |
| Exercise price | | Shares | | Weighted average exercise price | | Weighted average remaining contractual life (years) | | Shares | | Weighted average exercise price | |
|
| |
| |
| |
| |
| |
| |
| $ | 0.16 | | | 19,246 | | $ | 0.16 | | | 4.83 | | | 19,128 | | $ | 0.16 | |
| | 0.24 | | | 20,598,749 | | | 0.24 | | | 7.87 | | | 9,079,107 | | | 0.24 | |
| | 0.80 | | | 434,400 | | | 0.80 | | | 8.09 | | | 217,450 | | | 0.80 | |
| | 1.00 | | | 20,000 | | | 1.00 | | | 8.01 | | | 20,000 | | | 1.00 | |
| | 7.79 | | | 11,740 | | | 7.79 | | | 7.74 | | | 5,869 | | | 7.79 | |
| | 17.98 | | | 68,416 | | | 17.98 | | | 5.37 | | | 46,498 | | | 17.98 | |
| | 20.78 | | | 27,136 | | | 20.78 | | | 5.01 | | | 27,130 | | | 20.78 | |
| | 23.38 | | | 161,495 | | | 23.38 | | | 6.80 | | | 118,696 | | | 23.38 | |
| | 27.69 | | | 65,435 | | | 27.69 | | | 5.20 | | | 65,435 | | | 27.69 | |
| | 33.77 | | | 87,318 | | | 33.77 | | | 6.12 | | | 71,622 | | | 33.77 | |
| | 41.57 | | | 18,774 | | | 41.57 | | | 5.99 | | | 18,764 | | | 41.57 | |
| | | |
|
| |
|
| |
|
| |
|
| |
|
| |
| | | | | 21,512,709 | | $ | 0.77 | | | 7.83 | | | 9,689,699 | | $ | 1.20 | |
| | | |
|
| |
|
| |
|
| |
|
| |
|
| |
In February 2003, the Company offered option holders the opportunity to exchange certain options granted at $0.80 per share during 2002. For each option exchanged, the option holder received one option at the then fair market value of the Company’s common stock six months and one day after the exchange period expired. Options to purchase 1,906,600 shares of Common stock were exchanged and reissued at the strike price of $0.24 per share under this program in September 2003.
In connection with certain options granted to employees during 2000, the Company recorded $2,439,476 of deferred compensation. These amounts represent the difference between the fair market value of the Company’s Common stock on the date of grant and the exercise price of options to purchase 398,838 shares of the Company’s Common stock. Deferred compensation is amortized over the vesting periods of the options, which range from immediate vesting to periods of up to four years. For 2002 and 2001, $4,175 and $652,409 of deferred compensation, net of forfeitures, was charged to expense, respectively.
S-26
NOTE J – COMMITMENTS AND CONTINGENCIES
Lease commitments
The Company leases its main office facility and computer software and equipment. Future minimum lease payments under operating and capital leases that have initial or remaining noncancelable lease terms in excess of one year at December 31, 2003, are:
| Year | | Operating Leases | | Capital Leases | |
|
| |
| |
| |
| 2004 | | $ | 2,340,595 | | $ | 55,428 | |
| 2005 | | | 1,593,859 | | | 55,428 | |
| 2006 | | | 1,622,356 | | | 21,503 | |
| 2007 | | | 1,480,138 | | | 12,567 | |
| 2008 | | | 1,480,138 | | | 4,189 | |
| Thereafter | | | 1,480,138 | | | — | |
| | |
|
| |
|
| |
| Total minimum lease payments | | $ | 9,997,224 | | | 149,115 | |
| | |
|
| | | | |
| Less amount representing interest | | | | | | (26,034 | ) |
| | | | | |
|
| |
| Present value of minimum lease payments | | | | | | 123,081 | |
| Less current portion | | | | | | (41,380 | ) |
| | | | | |
|
| |
| Long-term portion of minimum lease payments | | | | | $ | 81,701 | |
| | | | | |
|
| |
Rent expense amounted to $2,877,175, $2,716,854 and $2,114,340 for 2003, 2002 and 2001, respectively.
Litigation
The Company is involved, from time to time, in various legal matters and claims which are being defended and handled in the ordinary course of business. None of these matters are expected, in the opinion of management, to have a material adverse effect on the financial position or results of operations of the Company.
Employment agreements
The Company has employment agreements with certain officers of the Company. The agreements provide for, among other things, salaries, bonuses, stock options, and severance payments.
Government regulation
Management believes, based upon consultation with legal counsel, that the Company is not required to be licensed by the Office of the Comptroller of the Currency, the Federal Reserve Board or other federal or state agencies that regulate or monitor banks or other providers of electronic commerce. However, the Company may be periodically examined by banking authorities since the Company is a supplier of services to financial institutions. Laws regulating internet commerce may be enacted to address issues such as, trust accounting, user privacy, pricing, content, taxation and the characteristics and quality of online products and services, among other things. If enacted, these laws could have a material adverse effect on the Company’s business.
S-27
NOTE K – INCOME TAXES
The reconciliation of the statutory federal income tax rate to the Company’s effective income tax rate is as follows:
| | Year ended December 31 | |
| |
| |
| | 2003 | | 2002 | | 2001 | |
| |
| |
| |
| |
Statutory federal income tax rate | | | 34.0 | % | | 34.0 | % | | 34.0 | % |
State income taxes, net of federal tax benefit | | | 5.9 | % | | 5.9 | % | | 6.3 | % |
Nondeductible expenses | | | (0.4 | )% | | (0.3 | )% | | (3.3 | )% |
Sale of New Jersey NOL | | | (2.7 | )% | | (2.4 | )% | | 0.0 | % |
Net operating loss | | | (39.6 | )% | | (39.6 | )% | | (37.0 | )% |
| |
|
| |
|
| |
|
| |
| | | (2.7 | )% | | (2.4 | )% | | 0.0 | % |
| |
|
| |
|
| |
|
| |
The Company participates in the New Jersey Emerging Technology and Biotechnology Financial Assistance Program (the Program). Under the Program, the Company received net proceeds of $250,942 and $291,518 in 2003 and 2002, respectively, in exchange for the rights to approximately $3.2 million and $3.7 million of its unused New Jersey NOL carry-forwards. These transactions have been recorded as an income tax benefit in the accompanying consolidated statements of operations.
Deferred taxes are determined based upon the estimated future tax effects of differences between the financial statements and income tax basis of assets and liabilities given the provisions of the enacted tax laws. The tax effect of temporary differences that give rise to deferred taxes are as follows:
| | December 31 | |
| |
| |
| | 2003 | | 2002 | |
| |
| |
| |
| Deferred tax assets: | | | | | | | |
| Net operating loss carry-forwards | | $ | 34,500,000 | | $ | 29,400,000 | |
| Deferred compensation | | | 2,100,000 | | | 2,100,000 | |
| Development costs | | | 300,000 | | | 300,000 | |
| Accruals and reserves not currently deductible | | | 900,000 | | | 800,000 | |
| Property and equipment | | | — | | | 300,000 | |
| |
|
| |
|
| |
| Total deferred tax assets | | | 37,800,000 | | | 32,900,000 | |
| Deferred tax liabilities: | | | | | | | |
| Property and equipment | | | (1,600,000 | ) | | — | |
| |
|
| |
|
| |
| Total deferred tax liabilities | | | (1,600,000 | ) | | — | |
| |
|
| |
|
| |
| Net deferred tax asset, prior to valuation allowance | | | 36,200,000 | | | 32,900,000 | |
| Less: valuation allowance | | | (36,200,000 | ) | | (32,900,000 | ) |
| |
|
| |
|
| |
| Net deferred tax asset | | $ | — | | $ | — | |
| |
|
| |
|
| |
| | | | | | | | | | | | |
S-28
NOTE K – INCOME TAXES - continued
As of December 31, 2003, the Company had net operating loss carry-forwards totaling approximately $86,000,000 for federal tax purposes. The availability of the net operating loss carry-forwards and future tax deductions to reduce taxable income is subject to various limitations under Section 382 of the Internal Revenue Code of 1986, as amended (Code), in the event of a further ownership change. This section states that after reorganization or other changes in corporate ownership (50% cumulative change in ownership over a three year period), the use of certain carry-forwards may be limited or prohibited. Due to the uncertainty surrounding the realization of the net deferred tax asset, management has provided a full allowance. As of December 31, 2003, the Company has net operating loss carry-forwards of approximately $117,000,000 for state tax purposes.
Net operating loss carry-forward amounts and expiration dates for both federal and state purposes are as follows:
Federal | | Net Operating Loss | | Expiration Date | |
| |
| |
| |
Net operating loss carry-forwards | | | | | | | |
1995 | | $ | 1,600,000 | | | 2015 | |
1996 | | | 2,000,000 | | | 2016 | |
1997 | | | 2,000,000 | | | 2017 | |
1998 | | | 3,000,000 | | | 2018 | |
1999 | | | 12,000,000 | | | 2019 | |
2000 | | | 28,400,000 | | | 2020 | |
2001 | | | 16,000,000 | | | 2021 | |
2002 | | | 9,400,000 | | | 2022 | |
2003 | | | 11,600,000 | | | 2023 | |
| |
|
| | | | |
| | $ | 86,000,000 | | | | |
| |
|
| | | | |
State | | Net Operating Loss | | Expiration Date | |
| |
| |
| |
Net operating loss carry-forwards | | | | | | | |
1999 | | $ | 11,000,000 | | | 2008 | |
2000 | | | 28,400,000 | | | 2009 | |
2001 | | | 49,000,000 | | | 2010 | |
2002 | | | 17,000,000 | | | 2011 | |
2003 | | | 11,600,000 | | | 2012 | |
| |
|
| | | | |
| | $ | 117,000,000 | | | | |
| |
|
| | | | |
NOTE L – EMPLOYEE BENEFIT PLAN
The Company has a Section 401(k) retirement savings plan (the 401(k) Plan). The 401(k) Plan allows employees to contribute from 2% to 15% of their annual compensation subject to statutory limitations. Company contributions to the 401(k) Plan are discretionary. In past years, the Company, at its discretion, has made matching contributions of 50% to 100% of the first 6% of employee contributions. For 2003, 2002 and 2001, the Company made matching contributions of $292,780, $288,451 and $440,435, respectively, to the 401(k) Plan.
S-29
NOTE M – CONCENTRATION OF CREDIT RISK
For 2003, 2002 and 2001, the Company had two, three and one customer(s) which accounted for 35%, 51% and 22% of total revenues, respectively. At December 31, 2003 and 2002, the Company had aggregate accounts receivable from these customers of $278,325 and $1,421,367, respectively. The loss of one or more of these customers could have a materially adverse effect on the Company’s business. During the fourth quarter 2003, the Company lost one customer which accounted for 18% of 2003 total revenues.
NOTE N – RELATED PARTY TRANSACTONS
The Company provides services to a customer who is also a stockholder. The Company recognized revenue totaling $301,606, $323,728 and $2,537,765 for 2003, 2002 and 2001, respectively, related to this arrangement. The Company had an accounts receivable balance of $46,408 and $40,865 due from this customer at December 31, 2003 and 2002, respectively.
The Company receives banking services from a vendor who is also a stockholder. The Company paid $1,976,584, $1,430,765 and $571,808 in fees to this vendor in 2003, 2002 and 2001, respectively, and received interest income of $567,725, $424,702 and $193,393 in 2003, 2002 and 2001, respectively.
NOTE O – SUBSEQUENT EVENTS
On March 25, 2004, the Company sold 34,333,333 shares of Series D-1 at $0.30 per share for proceeds of $10,300,000. In addition, the Series D-1 investors received warrants to purchase 8,583,333 shares of Series D-1 at $0.30 per share.
The terms of the Series A-1, B-1, C-1 and D-1 remained the same except the mandatory redemption date was extended to March 31, 2008 for Series D-1 and September 30, 2008 for Series A-1, B-1 and C-1.
In connection with the issuance of the Series D-1 and warrants on March 25, 2004, the holders of the Series A-1, B-1 and C-1 agreed to waive the anti-dilution provisions of these securities. As such, no adjustment was made to the conversion features of the Series A-1, B-1 and C-1 as a result of this issuance of Series D-1.
S-30